tiprankstipranks
FitLife Brands (FTLF)
NASDAQ:FTLF
US Market
Want to see FTLF full AI Analyst Report?

FitLife Brands (FTLF) AI Stock Analysis

40 Followers

Top Page

FTLF

FitLife Brands

(NASDAQ:FTLF)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
$11.00
▼(-22.70% Downside)
Action:Reiterated
Date:05/23/26
Overall score is driven primarily by solid financial fundamentals (strong revenue growth, still-healthy margins, and good cash conversion) tempered by higher leverage and margin compression. Technicals are a notable drag with the stock below key longer-term moving averages and negative MACD. Valuation is reasonable at ~19x earnings, while the earnings call suggests credible growth drivers and deleveraging intent but ongoing margin and execution/integration headwinds.
Positive Factors
Sustained Revenue Growth
Multi-year top-line expansion demonstrates successful scale and product-market fit across the brand portfolio. Rising revenue increases operating leverage, supports investment in marketing and distribution, and provides a larger base to absorb integration costs while enabling strategic reinvestment over the next 2–6 months.
Negative Factors
Elevated Leverage
Material post-acquisition indebtedness constrains financial flexibility and amplifies sensitivity to cash-flow volatility. Ongoing interest and amortization reduce free cash available for growth spending and make execution riskier if sales or margins slip, pressuring strategic optionality over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Multi-year top-line expansion demonstrates successful scale and product-market fit across the brand portfolio. Rising revenue increases operating leverage, supports investment in marketing and distribution, and provides a larger base to absorb integration costs while enabling strategic reinvestment over the next 2–6 months.
Read all positive factors

FitLife Brands (FTLF) vs. SPDR S&P 500 ETF (SPY)

FitLife Brands Business Overview & Revenue Model

Company Description
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for pro...
How the Company Makes Money
FitLife Brands makes money primarily by selling nutritional supplements and related wellness products under its brand portfolio. Its core revenue stream is product sales, with a significant portion generated through direct-to-consumer channels (co...

FitLife Brands Earnings Call Summary

Earnings Call Date:May 14, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Aug 17, 2026
Earnings Call Sentiment Neutral
The call presented a mix of strong top-line growth driven by the Irwin acquisition, meaningful wholesale expansion (+166% wholesale revenue) and clear momentum in Irwin’s Amazon business and subscriber growth, alongside active investments in advertising and new retail placements (Kroger). However, the benefits are partially offset by lower consolidated gross margins (37.6% vs 43.1% prior year), Legacy FitLife revenue and contribution declines (~22% revenue decline; contribution -27%), a modest decline in Adjusted EBITDA (-3%), acquisition-related amortization/interest pressure, Irwin organic softness (adjusted -13%) impacted by out-of-stocks and some unresolved Amazon channel issues. Overall the positives and negatives are balanced — showing progress and clear growth drivers but with important margin, integration and operational challenges that need continued execution.
Positive Updates
Strong Consolidated Revenue Growth
Total revenue of $25.3M in Q1 2026, up 59% year-over-year, driven primarily by the acquisition of Irwin.
Negative Updates
Decline in Gross Margin
Company gross margin declined to 37.6% in Q1 2026 from 43.1% in Q1 2025, driven primarily by Irwin's historically lower margin profile (Irwin GM 34.0%).
Read all updates
Q1-2026 Updates
Negative
Strong Consolidated Revenue Growth
Total revenue of $25.3M in Q1 2026, up 59% year-over-year, driven primarily by the acquisition of Irwin.
Read all positive updates
Company Guidance
On the call FitLife provided forward-looking color that emphasized improving Irwin economics and ongoing deleveraging: management expects Irwin gross margins to continue increasing over time as supply‑chain fixes and SKU setups are completed, and believes Irwin’s Amazon business can reach at least $1.0M per month (Amazon sales trended from ~ $500k in Dec‑2025 to ~$800k in March and ~ $900k in April, with subscriber counts rising from ~500 at the start of Q1 to ~3,600 at quarter‑end and over 5,700 today); Irwin generated $12.8M in Q1 (80% wholesale / 20% online) with a 34.0% gross margin and 31.3% contribution rate, while consolidated Q1 revenue was $25.3M (+59% YoY) — wholesale $14.1M (56% of revenue, +166% YoY) and online $11.2M (44%, +6% YoY) — consolidated gross margin was 37.6% (down from 43.1% a year ago), adjusted EBITDA was $3.3M (‑3% YoY) and net income was $1.7M (vs. $2.0M); management noted organic Irwin revenue was down ~13% YoY after adjustments (with ~$1.0–$1.5M+ of that due to out‑of‑stocks), advertising spend for Irwin rose to $358k in Q1 (vs. $182k in Q4 and $72k in Q3), shipments in transit shifted ~$1.0M from March into ~$1.65M in April, the term loan balance is $37.6M after a ~$1.5M amortization and the revolver is $4.2M after a $1.4M paydown, and the company intends to deploy excess free cash flow to further reduce indebtedness; near‑term commercial catalysts include launching 2 MusclePharm SKUs into ~700–800 Kroger stores in June and adding 8–10 SKUs on Amazon Canada later in Q2.

FitLife Brands Financial Statement Overview

Summary
Solid growth and profitability with good cash conversion: revenue expanded strongly into TTM and margins remain healthy (TTM gross margin ~38.6%, operating margin ~12–13%) with free cash flow roughly matching net income. Offsets are margin compression versus prior years and a meaningfully higher leverage profile (debt-to-equity ~1.0 in 2025/TTM) with weaker operating cash flow relative to debt in the latest periods.
Income Statement
74
Positive
Balance Sheet
58
Neutral
Cash Flow
66
Positive
BreakdownMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue81.46M64.47M52.70M28.80M27.91M
Gross Profit31.45M28.08M21.43M12.03M12.50M
EBITDA10.51M13.35M8.12M5.89M6.29M
Net Income6.33M8.98M5.30M4.43M5.41M
Balance Sheet
Total Assets106.32M58.53M55.35M25.71M21.51M
Cash, Cash Equivalents and Short-Term Investments1.65M4.47M1.14M13.28M9.90M
Total Debt45.25M13.46M20.15M103.00K158.00K
Total Liabilities62.68M22.41M28.31M4.32M4.16M
Stockholders Equity43.64M36.13M27.04M21.39M17.35M
Cash Flow
Free Cash Flow7.40M9.60M4.11M4.13M4.48M
Operating Cash Flow7.44M9.61M4.22M4.13M4.48M
Investing Cash Flow-42.54M-10.00K-35.99M0.00-529.00K
Financing Cash Flow32.09M-6.98M20.30M-750.00K-390.00K

FitLife Brands Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price14.23
Price Trends
50DMA
10.70
Negative
100DMA
13.04
Negative
200DMA
15.65
Negative
Market Momentum
MACD
-0.06
Negative
RSI
49.67
Neutral
STOCH
38.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTLF, the sentiment is Neutral. The current price of 14.23 is above the 20-day moving average (MA) of 9.72, above the 50-day MA of 10.70, and below the 200-day MA of 15.65, indicating a neutral trend. The MACD of -0.06 indicates Negative momentum. The RSI at 49.67 is Neutral, neither overbought nor oversold. The STOCH value of 38.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FTLF.

FitLife Brands Risk Analysis

FitLife Brands disclosed 13 risk factors in its most recent earnings report. FitLife Brands reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

FitLife Brands Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$384.41M20.5312.30%7.26%104.70%
63
Neutral
$67.75M10.0117.78%2.81%-12.15%-38.04%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
$97.39M19.3815.30%42.27%-33.19%
60
Neutral
$1.32B6.17-43.03%3.69%-16.34%
54
Neutral
$342.67M10.342.03%5.67%-73.96%
46
Neutral
$66.33M-0.15-140.70%-10.00%-98.14%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FTLF
FitLife Brands
10.07
-4.37
-30.26%
HLF
Herbalife
12.43
5.77
86.64%
NATR
Nature's Sunshine Products
21.85
7.02
47.34%
HAIN
Hain Celestial
0.78
-1.09
-58.45%
USNA
USANA Health
18.74
-10.68
-36.30%
LFVN
LifeVantage
5.61
-6.76
-54.63%

FitLife Brands Corporate Events

Executive/Board Changes
FitLife Brands Promotes Ryan Hansen to President Role
Positive
May 22, 2026
On May 18, 2026, FitLife Brands, Inc. appointed Executive Vice President Ryan Hansen as President, formalizing a leadership change that elevates the 38-year-old executive less than three years after he joined the company in November 2023. Hansen b...
Business Operations and StrategyFinancial Disclosures
FitLife Brands Posts Strong Q1 Revenue Amid Margin Pressure
Negative
May 14, 2026
FitLife Brands reported first-quarter 2026 results on May 14, showing total revenue of $25.3 million for the period ended March 31, 2026, up 59% year over year, driven largely by the Irwin acquisition and a 166% surge in wholesale revenue to $14.1...
Business Operations and StrategyFinancial Disclosures
FitLife Brands Highlights 2025 Results and Irwin Integration
Neutral
Apr 7, 2026
FitLife Brands reported its fourth-quarter and full-year 2025 performance on an April 1, 2026 earnings call, highlighting broad organic growth across most brand groupings except MRC and the first full-quarter contribution from Irwin Naturals, acqu...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
FitLife Brands Q4 2025 Results Highlight Irwin Acquisition
Neutral
Apr 1, 2026
FitLife Brands reported its fourth-quarter and full-year 2025 results on April 1, 2026, showing that the August 8 acquisition of Irwin Naturals drove a 73% year-on-year jump in quarterly revenue to $25.9 million and a 26% rise in annual revenue to...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 23, 2026